Immune correlates analysis of a phase 3 trial of the AZD1222 (ChAdOx1 nCoV-19) vaccine

In the phase 3 trial of the AZD1222 (ChAdOx1 nCoV-19) vaccine conducted in the U.S., Chile, and Peru, anti-spike binding IgG concentration (spike IgG) and pseudovirus 50% neutralizing antibody titer (nAb ID50) measured four weeks after two doses were assessed as correlates of risk and protection aga...

全面介紹

Saved in:

書目詳細資料
Main Authors:	David Benkeser, Youyi Fong, Holly Janes, Elizabeth J. Kelly, Ian Hirsch, Stephanie Sproule, Ann Marie Stanley, Jill Maaske, Tonya Villafana, Christopher R. Houchens, Karen Martins, Lakshmi Jayashankar, Flora Castellino, Victor Ayala, Christos J. Petropoulos, Andrew Leith, Deanne Haugaard, Bill Webb, Yiwen Lu, Chenchen Yu, Bhavesh Borate, Lars W. P. van der Laan, Nima S. Hejazi, Lindsay N. Carpp, April Randhawa, Michele P. Andrasik, James G. Kublin, Margaret Brewinski Isaacs, Mamodikoe Makhene, Tina Tong, Merlin L. Robb, Lawrence Corey, Kathleen M. Neuzil, Dean Follmann, Corey M. Hoffman, Ann R. Falsey, Magdalena E. Sobieszczyk, Richard A. Koup, Rubén O. Donis, Peter B. Gilbert
格式:	Artigo
語言:	英语
出版:	2023
在線閱讀:	https://doi.org/10.1038/s41541-023-00630-0 https://www.nature.com/articles/s41541-023-00630-0.pdf
標簽:	添加標簽沒有標簽, 成為第一個標記此記錄!

因特網

https://doi.org/10.1038/s41541-023-00630-0
https://www.nature.com/articles/s41541-023-00630-0.pdf

Immune correlates analysis of a phase 3 trial of the AZD1222 (ChAdOx1 nCoV-19) vaccine

因特網

相似書籍